The United Laboratories International Holdings Limited
ULIHF
$1.64
-$0.1543-8.60%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -1.54% | 1.37% | 3.21% | 8.89% | 15.44% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -1.54% | 1.37% | 3.21% | 8.89% | 15.44% |
| Cost of Revenue | 1.96% | 2.47% | 1.78% | 6.01% | 10.74% |
| Gross Profit | -5.63% | 0.07% | 4.92% | 12.46% | 21.46% |
| SG&A Expenses | -4.14% | -12.08% | -20.36% | -12.07% | -3.16% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 71.39% | -78.98% | -84.46% | -90.47% | -96.58% |
| Total Operating Expenses | 1.71% | 0.61% | -1.66% | 2.92% | 8.02% |
| Operating Income | -12.41% | 4.09% | 22.19% | 34.08% | 49.86% |
| Income Before Tax | -3.24% | 10.37% | 25.17% | 39.29% | 59.08% |
| Income Tax Expenses | -3.63% | 10.56% | 25.55% | 33.45% | 43.86% |
| Earnings from Continuing Operations | -3.15% | 10.32% | 25.08% | 40.80% | 63.20% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 267.23% | 198.82% | 93.01% | 180.97% | 600.00% |
| Net Income | -3.09% | 10.35% | 25.09% | 40.81% | 63.22% |
| EBIT | -12.41% | 4.09% | 22.19% | 34.08% | 49.86% |
| EBITDA | -9.72% | 3.76% | 17.96% | 27.24% | 38.96% |
| EPS Basic | -3.05% | 10.43% | 25.11% | 40.78% | 63.35% |
| Normalized Basic EPS | -3.36% | 9.51% | 23.10% | 35.22% | 52.08% |
| EPS Diluted | -3.05% | 10.43% | 25.11% | 40.78% | 63.35% |
| Normalized Diluted EPS | -3.36% | 9.51% | 23.10% | 35.22% | 52.08% |
| Average Basic Shares Outstanding | -0.01% | -0.01% | -0.01% | -0.08% | -0.15% |
| Average Diluted Shares Outstanding | -0.01% | -0.01% | -0.01% | -0.08% | -0.15% |
| Dividend Per Share | 9.09% | 31.12% | 62.13% | 78.59% | 101.80% |
| Payout Ratio | 0.76% | 0.63% | 0.54% | 0.37% | 0.18% |